Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity.
Kailash C. Bhol(Avaxia Biologics (United States)), A. R. Ahmed(Nirma University), Kannan Natarajan(Boston University), Valéria Aoki(Universidade de São Paulo), A. Mohimen(Boston University), Neville Nagarwalla(Boston University)
Cited by 203
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin
|New England Journal of Medicine|2006|452
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.
|Proceedings of the National Academy of Sciences|1995|249